| | | Single nucleotide variant (intron variant) | Cystic fibrosis | |
| | | Single nucleotide variant (splice acceptor variant) | Cystic fibrosis | |
| | | Single nucleotide variant (missense variant) | not specified +5 more | |
| | LOC111674475, CFTR (K536E) | Single nucleotide variant (missense variant) | Cystic fibrosis +2 more | |
| | CFTR, LOC111674475 (I539T) | Single nucleotide variant (missense variant) | not provided +5 more | |
| | CFTR, LOC111674475 (G542*) | Single nucleotide variant (nonsense) | Cystic fibrosis | |
| | CFTR, LOC111674475 (S549N) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (G551S) | Single nucleotide variant (missense variant) | ivacaftor response - Efficacy +1 more | GPathogenic; drug response |
| | CFTR, LOC111674475 (G551D) | Single nucleotide variant (missense variant) | Cystic fibrosis | |
| | CFTR, LOC111674475 (R553*) | Single nucleotide variant (nonsense) | Cystic fibrosis | |
| | CFTR, LOC111674475 (I556V) | Single nucleotide variant (missense variant) | CFTR-related disorders +3 more | GConflicting classifications of pathogenicity |
| | CFTR, LOC111674475 (A559P) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | CFTR, LOC111674475 (R560T) | Single nucleotide variant (missense variant) | Cystic fibrosis | |
| | | Single nucleotide variant (intron variant) | not specified +3 more | GConflicting classifications of pathogenicity |